CBI’s 10th Annual Guidelines for Disseminating Off-Label Information

Venue: Vienna

Location: Vienna, United States

Event Date/Time: Oct 16, 2008
Report as Spam

Description

Presentations and panel discussions from the FDA, DOJ, various U.S. Attorneys’ Offices and the former director of DDMAC highlighted the 2007 forum. Great discussion surrounded the role of the MSL in the dissemination of scientific information.
More than 120 people attended the 9th Annual event, representing companies including:
Abbott * Abraxis * Allergan * Alpharma * Amgen * Astellas *AstraZeneca * Baxter * Bayer * BioForm Medical * Boehringer Ingelheim *Boston Scientific * CSL Behring * Centocor * Cephalon * Cytyc Corp Eisai * Eli Lilly & Co. * Ethicon * Genentech * Genmab * ISTA * Innovex *Intendis * Johnson & Johnson * MGI Pharma * Medimmune * Millennium *Novartis * NovoNordisk * OSI Pharmaceuticals * Organon USA * Ortho McNeil Janssen * Par * Pfizer * Reliant * TAP * Takeda * Talecris Tibotec Therapeutics * Valeant Pharmaceuticals * Watson Laboratories
Areas being researched for 2008 include:
• Update from FDA/DDMAC
• Update on Enforcement Efforts and Recent Settlements
• Panels with U.S. Attorneys
• MSL Break-Out Sessions
• Ability to Provide Pharmacy Credits for Attending

Venue

Restrictions